SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,785.00    90.00 (1.34%)
Bid:
6,780.00
Ask:
6,790.00
Spread: 10.00 (0.147%)
Market Cap: £5.01b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Trading update

6 Jul 2010 07:00

RNS Number : 8527O
Spirax-Sarco Engineering PLC
06 July 2010
 



 

Spirax-Sarco Engineering plc

Tuesday 6th July 2010

 

TRADING UPDATE

 

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following update in respect of its trading for the six months ended 30th June 2010. Results for the first half-year are expected to be announced on 24th August 2010.

 

Since the AGM, trading conditions continue to be positive and sales for the first half-year were ahead 8% at constant currency, including a 2% contribution from acquisitions; also, the order book increased. Growth continues to be led by Watson-Marlow Pumps and in the steam business by the Americas and Asia Pacific, with EMEA mixed but overall flat. Exchange movements have been favourable and added 2% to sales on translation in the first half-year versus average exchange rates in the comparable period last year.

 

Adjusted operating profit margin1 shows a strong improvement over the 15.0% in the first half of 2009 and is expected to be above 19% for the first half of 2010. We have benefited from operational gearing from the increase in sales, last year's cost reduction measures, small exchange gains and a favourable product mix. Material costs have also been favourable but are rising and we anticipate this impacting the second half of the year. We are also increasing our investment in new product development and in market development to enhance our future growth prospects.

 

We continue to operate with a strong balance sheet and net cash balances at 30th June 2010 were £18m. As we have previously indicated, capital investment for this year is expected to be at a high level as we progress several major manufacturing projects, including our new plant in China that was opened last week and the consolidation onto one manufacturing site in Cheltenham.

 

 

1 The adjusted operating profit margin noted above excludes the amortisation of acquisition-related intangible assets and an £8m exceptional revaluation gain following the 25th May 2010 acquisition of our partners' 51% shareholding in our Mexican business.

 

 

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,200 people, of whom 1,200 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKKPDBABKDBOK
Date   Source Headline
8th Apr 20259:34 amRNSDirector/PDMR Shareholding
8th Apr 20259:32 amRNSNotice of AGM
27th Mar 20254:06 pmRNSDirector/PDMR Shareholding
27th Mar 20254:06 pmRNSDirector/PDMR Shareholding
19th Mar 202511:43 amRNSHolding(s) in Company
12th Mar 20257:00 amRNSDividend Declaration
11th Mar 20257:00 amRNS2024 Full Year Results
10th Mar 20251:42 pmRNSDirector/PDMR Shareholding
10th Feb 20252:23 pmRNSDirector/PDMR Shareholding
31st Jan 20259:00 amRNSBoard Appointment
14th Jan 20253:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSBoard Chair Succession
11th Dec 20241:53 pmRNSDirector/PDMR Shareholding
27th Nov 20244:18 pmRNSDirector/PDMR Shareholding
15th Nov 20241:19 pmRNSDirector/PDMR Shareholding
14th Nov 20247:00 amRNSTrading Update
16th Oct 20248:48 amRNSHolding(s) in Company
11th Oct 20241:50 pmRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSDirector/PDMR Shareholding
10th Oct 20243:29 pmRNSHolding(s) in Company
3rd Oct 20247:00 amRNSCapital Markets Event
18th Sep 20249:47 amRNSHolding(s) in Company
16th Sep 202410:12 amRNSHolding(s) in Company
13th Sep 202410:57 amRNSHolding(s) in Company
12th Aug 202410:44 amRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNS2024 Half Year Results
1st Jul 20247:05 amRNSConfirmation of CFO Start Date
5th Jun 20243:46 pmRNSChange of Name
29th May 20248:45 amRNSBoard Succession
15th May 20244:56 pmRNSResult of AGM
15th May 20247:00 amRNSAGM Trading Statement
10th Apr 20244:44 pmRNSDirector/PDMR Shareholding
26th Mar 20249:33 amRNSDirector/PDMR Shareholding
20th Mar 202410:00 amRNSDirector/PDMR Shareholding
18th Mar 20242:34 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNS2023 Full Year Results
22nd Feb 20247:00 amRNSSpirax-Sarco Engineering rebrands as Spirax Group
1st Feb 20243:38 pmRNSChange of Director Details
30th Jan 202411:15 amRNSFuture Board Change
17th Jan 20247:00 amRNSLeadership Succession
18th Dec 20237:00 amRNSChief Financial Officer Appointment
21st Nov 20239:15 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSShare Purchases
16th Nov 20237:00 amRNSTrading Update
11th Oct 20238:40 amRNSDirector/PDMR Shareholding
25th Aug 20239:30 amRNSHolding(s) in Company
25th Aug 20238:30 amRNSHolding(s) in Company
10th Aug 20237:00 amRNS2023 Half Year Results
8th Aug 20237:00 amRNSGroup Chief Executive Succession

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.